Lactose (India) Ltd.

BSE: LACTOSE · Pharmaceuticals · sector

₹102.35BSE close 2026-10-26

Key numbers

Market cap₹129 cr

Price₹102.35

52w high / low₹136 / ₹76

P/E18.6xSector median 27.9x

P/B2.0xSector median 2.9x

Book value₹51.5

Dividend yield–Sector median 0.48%

ROE11.2%Sector median 11.7%

ROCE12.0%Sector median 12.3%

OPM11.4%Sector median 14.0%

Debt / equity0.95xSector median 0.16x

EV/EBITDA9.8xSector median 18.6x

Interest cover2.7x

Current ratio1.10x

Sales growth 3y+35.4%Sector median +9.6%

Profit growth 3y+71.1%Sector median +13.3%

PEG0.26x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹1 cr vs borrowings ₹62 cr (FY26): borrowings are higher by ₹61 cr.
Operating profit covered interest 2.7x in the last 12 months.
Other income was 26% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹102.35 on 2026-10-26: -25.0% from the 52-week high, +34.7% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹228.85 · low ₹81.95

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	28	40	41	37	46	47
EBITDA	3	4	5	3	5	6
OPM %	12.3%	11.3%	12.8%	8.3%	11.0%	12.9%
Other income	0	0	0	1	0	1
Net profit	1	2	2	1	2	2
EPS (₹)	0.51	1.19	1.71	0.42	1.49	1.88
Revenue YoY					+64.8%	+18.7%
Profit YoY					+193.7%	+58.0%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	46	66	114	116	163	171
EBITDA	12	11	19	17	18	19
Net profit	2	1	7	5	6	7
EPS (₹)	2.10	0.96	5.39	4.10	4.82	5.50
Revenue growth		+43.2%	+73.1%	+2.2%	+40.3%	–
Profit growth		-50.6%	+461.2%	-24.0%	+17.4%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+35.4%	–	–
Net profit	+71.1%	–	–
EPS	+71.2%	–	–
Share price	–	-24.6% (2y)	-17.1%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	59	65
Borrowings	56	62
Cash & equivalents	5	1
Total assets	133	183
Fixed assets	52	68
Capital work in progress	10	0
Investments	0	0
Receivables	22	33
Inventory	25	56
Payables	11	38

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-0	6
Cash from investing	-16	-10
Cash from financing	19	1
Capex	14	10
Free cash flow	-15	-5

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	8.8%	9.4%
ROCE %	11.3%	10.8%
Debtor days	68	75
Inventory days	171	217
Payable days	74	146
Cash conversion cycle (days)	165	146
Working capital days	39	20

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
LACTOSE	₹129 cr	18.6x	2.0x	11.2%	12.0%	11.4%	+35.4%	–

All 185 companies in Pharmaceuticals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	LACTOSE
BSE code	524202
ISIN	INE058I01013
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.